Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis J Cruz

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Current Pharmaceutical Design|December 23, 2016
Targeting the Brain with NanomedicineFelix Rueda, Luis J Cruz
Frontiers in Chemistry|July 14, 2020
Recent Advances in Rare-Earth-Doped Nanoparticles for NIR-II Imaging and Cancer TheranosticsZhenfeng Yu, Christina Eich, Luis J Cruz
Chemmedchem|May 22, 2007
Synthesis and structure-activity relationship of cytotoxic marine cyclodepsipeptide IB-01212 analoguesLuis J Cruz, Andres Francesch, Carmen Cuevas, et al.
Molecular Immunology|October 19, 2004
Broader cross-reactivity after conjugation of V3 based multiple antigen peptides to HBsAgEnrique Iglesias, Julio C Aguilar, Luis J Cruz, et al.
Biomaterials|July 5, 2011
The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cellsLuis J Cruz, Paul J Tacken, Remco Fokkink, et al.
Current Pharmaceutical Biotechnology|July 29, 2020
Enhanced Intracellular Delivery of Curcumin by Chitosan-Lipoic Acid as Reduction-Responsive NanoparticlesSomayeh Rezaei, Soheila Kashanian, Yadollah Bahrami, et al.
Frontiers in Genome Editing|November 21, 2022
Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseasesLuis J Cruz, Somayeh Rezaei, Frank Grosveld, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2021
<sup>19</sup>F-nanoparticles: Platform for in vivo delivery of fluorinated biomaterials for <sup>19</sup>F-MRIAlvja Mali, Eric L Kaijzel, Hildo J Lamb, et al.
Molecules (Basel, Switzerland)|March 11, 2020
Redox-Sensitive and Hyaluronic Acid-Functionalized Nanoparticles for Improving Breast Cancer Treatment by Cytoplasmic 17α-Methyltestosterone DeliverySomayeh Rezaei, Soheila Kashanian, Yadollah Bahrami, et al.
Molecular Pharmaceutics|August 19, 2010
The antitumoral depsipeptide IB-01212 kills Leishmania through an apoptosis-like process involving intracellular targetsJuan R Luque-Ortega, Luis J Cruz, Fernando Albericio, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Current Pharmaceutical Design|December 23, 2016
Targeting the Brain with NanomedicineFelix Rueda, Luis J Cruz
Frontiers in Chemistry|July 14, 2020
Recent Advances in Rare-Earth-Doped Nanoparticles for NIR-II Imaging and Cancer TheranosticsZhenfeng Yu, Christina Eich, Luis J Cruz
Chemmedchem|May 22, 2007
Synthesis and structure-activity relationship of cytotoxic marine cyclodepsipeptide IB-01212 analoguesLuis J Cruz, Andres Francesch, Carmen Cuevas, et al.
Molecular Immunology|October 19, 2004
Broader cross-reactivity after conjugation of V3 based multiple antigen peptides to HBsAgEnrique Iglesias, Julio C Aguilar, Luis J Cruz, et al.
Biomaterials|July 5, 2011
The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cellsLuis J Cruz, Paul J Tacken, Remco Fokkink, et al.
Current Pharmaceutical Biotechnology|July 29, 2020
Enhanced Intracellular Delivery of Curcumin by Chitosan-Lipoic Acid as Reduction-Responsive NanoparticlesSomayeh Rezaei, Soheila Kashanian, Yadollah Bahrami, et al.
Frontiers in Genome Editing|November 21, 2022
Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseasesLuis J Cruz, Somayeh Rezaei, Frank Grosveld, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2021
<sup>19</sup>F-nanoparticles: Platform for in vivo delivery of fluorinated biomaterials for <sup>19</sup>F-MRIAlvja Mali, Eric L Kaijzel, Hildo J Lamb, et al.
Molecules (Basel, Switzerland)|March 11, 2020
Redox-Sensitive and Hyaluronic Acid-Functionalized Nanoparticles for Improving Breast Cancer Treatment by Cytoplasmic 17α-Methyltestosterone DeliverySomayeh Rezaei, Soheila Kashanian, Yadollah Bahrami, et al.
Molecular Pharmaceutics|August 19, 2010
The antitumoral depsipeptide IB-01212 kills Leishmania through an apoptosis-like process involving intracellular targetsJuan R Luque-Ortega, Luis J Cruz, Fernando Albericio, et al.
Pageof 14